Keyphrases
Type 2 Diabetes Mellitus (T2DM)
71%
Patients with Coronary Artery Disease
55%
Insulin Sensitivity
51%
Liraglutide
50%
Coronary Artery Disease
48%
Weight Loss
47%
Type 2 Diabetic Patients
42%
Randomized Trial
41%
Glucagon-like
36%
Low-energy Diet
35%
Overweight Patient
35%
Aerobic Interval Training
34%
Stable Coronary Artery Disease
33%
Coronary Flow Reserve
33%
Skeletal muscle
33%
AIDS/HIV
33%
Glucose Metabolism
31%
Carbohydrates
28%
Placebo-controlled
27%
Randomized Double-blind
26%
Exercise Training
25%
Mitochondrial Respiration
25%
Body Composition
25%
β-cell Function
24%
HIV Patients
24%
Infected Patients
23%
High-protein Diet
21%
Triglycerides
20%
Heart Rate Variability
20%
VO2peak
19%
Non-diabetic
19%
Placebo
18%
New-onset Type 2 Diabetes
18%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
18%
Acute Effects
18%
Body Mass Index
18%
Obesity
18%
Metformin
18%
Opposite Effects
17%
Insulin Secretion
17%
Antiretroviral Therapy
17%
Highly Active Antiretroviral Therapy (HAART)
17%
Training Loss
16%
Systolic Function
16%
Pioglitazone
16%
Rosiglitazone
16%
Left Ventricular Ejection Fraction
16%
Copenhagen
16%
Insulin Resistance
15%
Hemoglobin A1c (HbA1c)
15%
Medicine and Dentistry
Coronary Artery Disease
100%
Maturity Onset Diabetes of the Young
71%
Human immunodeficiency virus
44%
Exercise
38%
Low Calorie Diet
37%
Insulin Release
34%
Diabetes
34%
Glucose Metabolism
33%
Liraglutide
33%
Insulin Sensitivity
32%
Coronary Flow Reserve
31%
Beta Cell
31%
Placebo
30%
Obesity
27%
Triacylglycerol
27%
Cell Function
26%
Patient with Overweight
25%
Protein Diet
24%
Patient with Type 2 Diabetes
19%
Antiretroviral Therapy
19%
Body Mass Index
18%
Diabetes Mellitus
18%
Urokinase Receptor
18%
Systolic Function
17%
Carbohydrate Diet
16%
Blood Pressure
16%
Glucagon Like Peptide 1
15%
